Chipiron

Breast Imaging Reimbursement, Quality, and Access Gaps

Breast Imaging Reimbursement, Quality, and Access Gaps

Insurance, cost, prior authorization, travel, workforce shortages, and uneven specialty access continue to limit recommended screening and MRI. A reported Curative policy removing authorization for 86% of MRIs is a potentially important but insufficiently documented payer signal; CPT 77046–77049 coverage and authorization remain variable.

Sources (2)
Updated Sep 30, 2026
Breast Imaging Reimbursement, Quality, and Access Gaps - Chipiron | NBot | nbot.ai